Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation.
暂无分享,去创建一个
Yiping Wang | Qing Li | Yuanyuan Shen | Z. Zhai | Zimin Sun | Huilan Liu | Aimei Zhang | Xiucai Xu | L. Geng
[1] D. Harris,et al. Correlation of the CD4+CD25high T‐regulatory cells in recipients and their corresponding donors to acute GVHD , 2007, Transplant international : official journal of the European Society for Organ Transplantation.
[2] N. Kadowaki,et al. FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation , 2007, International journal of hematology.
[3] W. Selby,et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.
[4] D. Klatzmann,et al. Ex Vivo-Expanded CD4+CD25+ Immunoregulatory T Cells Prevent Graft-versus-Host-Disease by Inhibiting Activation/Differentiation of Pathogenic T Cells1 , 2006, The Journal of Immunology.
[5] A. Hess. Modulation of graft-versus-host disease: role of regulatory T lymphocytes. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] R. Sackstein. A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] J. Ritz,et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. , 2005, Blood.
[8] J. Treleaven,et al. Cytokine profiles in stem cell transplantation: Possible use as a predictor of graft-versus-host disease , 2005, Hematology.
[9] M. Schilham,et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. , 2005, Human immunology.
[10] L. Verdonck,et al. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions. , 2005, Haematologica.
[11] T. Iwasaki. Recent advances in the treatment of graft-versus-host disease. , 2004, Clinical medicine & research.
[12] C. Thoburn,et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. , 2004, Blood.
[13] J. Berzofsky,et al. Immunoregulatory T cells in tumor immunity. , 2004, Current opinion in immunology.
[14] C. Craddock,et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. , 2004, Blood.
[15] J. Lynch,et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. , 2003, Blood.
[16] M. Roncarolo,et al. IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function. , 2003, Blood.
[17] M. Remberger,et al. Serum levels of cytokines correlate to donor chimerism and acute graft‐vs.‐host disease after haematopoietic stem cell transplantation , 2003, European journal of haematology.
[18] Bryon D Johnson,et al. CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[19] David Klatzmann,et al. CD4+CD25+ Immunoregulatory T Cells , 2002, The Journal of experimental medicine.
[20] C. Fathman,et al. Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation , 2002, The Journal of experimental medicine.
[21] M. Leffell,et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] K. Cleary,et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. , 2001, Blood.
[23] R. Noelle,et al. Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade , 2001, The Journal of experimental medicine.
[24] F. Powrie,et al. IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo1 , 2001, The Journal of Immunology.
[25] Jianmin Wang,et al. [Roles of Cytokines in Acute Graft-Versus-Host Disease] , 2000, Zhongguo shi yan xue ye xue za zhi.
[26] N. Ueno,et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. , 1999, Blood.
[27] H. V. van Houwelingen,et al. Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. , 1999, Transplantation.
[28] W. Krenger,et al. Graft-versus-host disease and the Th1/Th2 paradigm , 1996, Immunologic research.
[29] E D Thomas,et al. 1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.
[30] A. Rimm,et al. Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.
[31] M. Hirokawa,et al. Serum tumor necrosis factor-alpha levels in allogeneic bone marrow transplant recipients with acute leukemia. , 1989, The Tohoku journal of experimental medicine.